期刊文献+

能谱CT定量指标在鉴别诊断非小细胞肺癌转移淋巴结与非转移淋巴结中的价值 被引量:20

Differentiating Metastatic Lymph Nodes from Non-Metastatic Lymph Nodes in Non-SmallCell Lung Cancer: the Value of Spectral CT Quantitative Indicators
下载PDF
导出
摘要 【目的】评估能谱CT定量指标鉴别诊断非小细胞肺癌(NSCLC)转移淋巴结与非转移淋巴结的价值。【方法】对48例非小细胞肺癌转移淋巴结(n=34)与非转移淋巴结(n=40)的CT平扫、动脉期及静脉期能谱定量指标进行比较。【结果】转移淋巴结平扫及动脉期碘基物质密度、平扫及动脉期有效原子序数、平扫及动脉期标化有效原子序数、动脉期标化碘基物质密度均低于非转移淋巴结组,差异均具有统计学意义(P<0.05),依据动脉期标化有效原子序数<0.7278,诊断淋巴结为恶性的正确几率分别为83.3%。依据动脉期标化碘基物质密度>0.1574,诊断淋巴结为良性的正确几率分别为86.7%。【结论】能谱CT定量指标对鉴别诊断非小细胞肺癌转移淋巴结与非转移淋巴结提供定量分析,提高非小细胞肺癌的淋巴结分期。 [Objectives] To evaluate the value of spectral CT quantitative indicators in the differential diagnosis of metastatic and non-metastatic lymph node in NSCLC.[Methods] 48 patients with NSCLC were enrolled including metastatic lymph nodes group (n=34) and non-metastatic lymph nodes group (n =40).Unenhanced,arterial phase and venous phase enhanced spectral CT quantitative indicators were compared between metastatic and non-metastatic lymph nodes.[Results] Iodine Concentrations,effective Z value,normalized effective Z value of metastatic lymph node group were statistically lower than that of non-metastatic lymph node group both in unenhanced phase and in arterial phase,same result was found as well as normalized Iodine Concentrations in arterial phase (P < 0.05).The accuracy of using normalized effective Z value in arterial phase < 0.7278 as criteria to get a diagnosis of metastatic lymph node was 83.3%.The accuracy of using normalized Iodine Concentrations in arterial phase > 0.1574 as criteria to get a diagnosis of non-metastatic lymph node was 86.7%.[Conclusions] Spectral CT quantitative indicators can provide quantitative analysis in differential diagnosis of metastatic and non-metastatic lymph node in NSCLC,and improving the diagnostic accuracy of N staging of NSCLC.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2014年第5期738-743,共6页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省医学科研基金(A2013218)
关键词 非小细胞肺癌 淋巴结转移 体层摄影术 X线计算机 能谱成像 non-small-cell lung cancer lymph node metastasis tomography, X-ray computed gemstone spectral imaging
  • 相关文献

参考文献21

  • 1Pirozynski M. 100 years of lung cancer[J]. Respir Med, 2006, 100(12) : 2073-2084.
  • 2Rami-Porta R, Crowley J J, Goldstraw P. The revised TNM staging system for lung cancer [J]. Ann Thorac Cardiovasc Surg, 2009, 15(1): 4-9.
  • 3Takamochi K, Nagai K, Yoshida J, et al. The role of computed tomographic scanning in diagnosing mediastinal node involvement in non-small cell lung cancer[J]. J Thorac Cardiovasc Surg, 2000, 119(6): 1135-1140.
  • 4Lau CL, Harpole DJ. Noninvasive clinical staging modalities for lung cancer [ J ]. Semin Surg Oncol, 2000, 18(2): 116-123.
  • 5Dwamena BA, Sonnad SS, Angobaldo JO, et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s:meta-analytic comparison of PET and CT[J]. Radiology, 1999, 213(2) : 530-536.
  • 6Boll D T, Patil N A, Panlson E K, et al. Focal cystic high-attenuation lesions : characterization in renal phantom by using photon-counting spectral CT:improved differentiation of lesion composition [ J]. Radiology, 2010, 254(1) : 270-276.
  • 7饶艳莺,杨文洁,刘博,曹丽秀,柴维敏,陈克敏.双能CT对肺癌淋巴结分期的可行性研究:碘浓度与纵隔淋巴结转移的相关性分析[J].放射学实践,2013,28(7):759-762. 被引量:16
  • 8Eisenhauer E A, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline version 1.1 [J]. Eur J Cancer, 2009, 45(2) : 228-247.
  • 9Rusch VW, Asamura H, Watanabe H, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventhedition of the TNM classification for lung cancer [J]. J Thorac Oncol, 2009, 4(5): 568-577.
  • 10Kamiyoshihara M, Kawashima O, Ishikawa S, et al. Mediastinal lymph node evaluation by computed tomographic scan in lung cancer[J]. J Cardiovasc Surg: Torino, 2001, 42(1) : 119-124.

二级参考文献18

  • 1孙异临,高进(指导),杨简(指导),李宝贵.在淋巴道转移过程中癌细胞在淋巴结内的命运及淋巴结的改变[J].解剖学报,1982(1):97-102. 被引量:4
  • 2Nair A, Klusmann MJ,Jogeesvaran KH, et al. Revisions to the TNM staging of non small cell lung cancer : rationale, clinicoradio logic implications, and persislent limitations[J]. RadioGraphics, 2011,31(1) :215-238.
  • 3Ohno Y, Koyama H, Yoshikawa T, et al. N stage disease in pa- tients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging,diffu sion-weighted MR imaging,and fluorodeoxyglucose PET/CT[J]. Radiology,2011,261 (2) :605-615.
  • 4Schmid-Bindert G, Henzler T,Chu TQ, et al. Functional imaging of lung cancer using dual energy CT: how does iodine related at tenuation correlate with standardized uptake value of lSFDG- PET CT[J]. Eur Radioh2012,22(1):93 -103.
  • 5Johnson TR, Krauss B, Sedlmair M, et al. Material differentiation by dual energy CT: initial experience [ J ]. Eur Radiol, 2007, 17 (6):1510- 1517.
  • 6Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer sta ging system[J]. Chest, 2009,136( 1 ) : 260-271.
  • 7Schafer JF, Vollmar J, Schick F, et al. Imaging diagnosis of solitary pulmonary nodules on an open low field MRI system- comparison of two MR sequences with spiral CT[J]. R6fo, 2002,174(9):1107- 1114.
  • 8Schaefer JF, Schneider V, Vollmar J, et al. Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MR1 and tumor angiogenesis[J]. Lung Cancer, 2006,53(1) :39-49.
  • 9Chae EJ,Song JW,Seo JB,et al. Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules:initial experience [J]. Radiology, 2008,249(2) :671-681.
  • 10Lv P, Lin XZ, Li J, et al. Differentiation of small hepatic hemaw gioma from small hepatocellular carcinoma: recently introduced spectral CT method[J]. Radiology, 2011,259(3) : 720- 729.

共引文献15

同被引文献166

引证文献20

二级引证文献174

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部